Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Gains from Investment Securities (2022 - 2025)

Mangoceuticals' Gains from Investment Securities history spans 4 years, with the latest figure at $2.2 million for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 16075.4% to $2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.2 million, a 16075.4% increase, with the full-year FY2025 number at $2.2 million, up 16075.4% from a year prior.
  • Gains from Investment Securities hit $2.2 million in Q4 2025 for Mangoceuticals, roughly flat from $2.2 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for MGRX hit a ceiling of $2.4 million in Q1 2024 and a floor of $10000.0 in Q3 2023.
  • Historically, Gains from Investment Securities has averaged $824999.7 across 4 years, with a median of $156666.0 in 2024.
  • The widest YoY moves for Gains from Investment Securities: up 16075.4% in 2025, down 93.38% in 2025.
  • Tracing MGRX's Gains from Investment Securities over 4 years: stood at $33333.0 in 2022, then surged by 430.0% to $176666.0 in 2023, then crashed by 92.45% to $13333.0 in 2024, then surged by 16075.4% to $2.2 million in 2025.
  • Business Quant data shows Gains from Investment Securities for MGRX at $2.2 million in Q4 2025, $2.2 million in Q3 2025, and $156666.0 in Q2 2025.